As one of the world's largest company and the New York Stock Exchange are registered to Pfizer, a leading pharmaceutical manufacturer, agreed to purchase Wyeth'i was 68 billion dollars. Board of Directors of both companies approved the agreement by Pfizer, Wyeth will pay for the dollar 50.19 per share.
This merger results in the health sector in the Pfizer world product diversity will become one of the highest company.
The owner of the new company will be based on calculations produced by the year 2012 came thanks to the diversity of drugs of any drug in the company's total revenue is expected to be over 10 per cent of the share.
In the statement on the subject, will gain power in the global scale thanks to the changing needs of the health sector Pfizer'ın in faster and more effective for the specified action will be.
The merger agreement through the consortium of banks, cash, stock exchange and debt financing for the purchase occurred in 22.5 billion dollars in commitments are made.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment